|
P-9019-96
|
Epigentek Group Inc
|
Epigenase m6A Methylase Activity/Inhibition Assay Kit (Colorimetric) [96 Assays]
|
|
|
|
|
HY-12010-100mg
|
MedChemexpress LLC
|
BMS-599626 (Hydrochloride) [CAS 873837-23-1]
|
|
Cancer-Kinase/protease
|
|
|
HY-12010-5mg
|
MedChemexpress LLC
|
BMS-599626 (Hydrochloride) [CAS 873837-23-1]
|
|
Cancer-Kinase/protease
|
|
|
HY-12010-50mg
|
MedChemexpress LLC
|
BMS-599626 (Hydrochloride) [CAS 873837-23-1]
|
|
Cancer-Kinase/protease
|
|
|
HY-12010-1mL
|
MedChemexpress LLC
|
BMS-599626 (Hydrochloride) [CAS 873837-23-1] (10mM in DMSO)
|
|
Cancer-Kinase/protease
|
|
|
HY-13016-10mg
|
MedChemexpress LLC
|
Cabozantinib [CAS 849217-68-1]
|
|
Cancer-Kinase/protease
|
|
|
HY-13016-100mg
|
MedChemexpress LLC
|
Cabozantinib [CAS 849217-68-1]
|
|
Cancer-Kinase/protease
|
|
|
HY-13016-200mg
|
MedChemexpress LLC
|
Cabozantinib [CAS 849217-68-1]
|
|
Cancer-Kinase/protease
|
|
|
HY-13016-5mg
|
MedChemexpress LLC
|
Cabozantinib [CAS 849217-68-1]
|
|
Cancer-Kinase/protease
|
|
|
HY-13016-50mg
|
MedChemexpress LLC
|
Cabozantinib [CAS 849217-68-1]
|
|
Cancer-Kinase/protease
|
|
|
HY-13016-500mg
|
MedChemexpress LLC
|
Cabozantinib [CAS 849217-68-1]
|
|
Cancer-Kinase/protease
|
|
|
HY-13016-1mL
|
MedChemexpress LLC
|
Cabozantinib [CAS 849217-68-1] (10mM in DMSO)
|
|
Cancer-Kinase/protease
|
|
|
HY-10408-10mg
|
MedChemexpress LLC
|
Ki20227 [CAS 623142-96-1]
|
|
COVID-19-immunoregulation
|
|
|
HY-10408-2mg
|
MedChemexpress LLC
|
Ki20227 [CAS 623142-96-1]
|
|
COVID-19-immunoregulation
|
|
|
HY-10408-5mg
|
MedChemexpress LLC
|
Ki20227 [CAS 623142-96-1]
|
|
COVID-19-immunoregulation
|
|
|
HY-10408-50mg
|
MedChemexpress LLC
|
Ki20227 [CAS 623142-96-1]
|
|
COVID-19-immunoregulation
|
|
|
HY-10408-1mL
|
MedChemexpress LLC
|
Ki20227 [CAS 623142-96-1] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|
|
sc-355981
|
Santa Cruz Biotechnology
|
Stem-Cell Factor/c-Kit Inhibitor, ISCK03 [CAS 945526-43-2]
|
|
|
|
